Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Explore effective methods to manage surprise expenses within budgeting. Reallocate funds smartly and keep your financial plan intact.
16,044 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Critics like the billionaire investor jeremy grantham call Bitcoin a mere speculative asset. This article argues why ...
A prominent asset manager has quietly ramped up its Bitcoin exposure, even as its massive stash remains underwater. T...
Global markets can offer growth outside the U.S. In this guide, we break down why international stocks may outperform...
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
A major issuer boosted its quarterly dividend by 16%, even as shares retreat. This article breaks down what that sign...
Delaying Medicare enrollment can cost you more than you expect. This guide explains how missing this medicare deadlin...
A single photo can trigger a flood of online chatter and real-world money decisions. This piece breaks down what a vi...
ClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...
A notable fund trimmed a sizable healthcare stake by roughly $6.5 million as the stock soared and revenue grew. Here’...
AI is advancing beyond chips. NVIDIA's networking revenue just signals a broader shift to end-to-end AI infrastructur...
Shopify delivered strong quarterly results, but the stock traded lower as guidance softened. This article explains wh...